mRNA |
bafilomycin A1 |
CTRPv2 |
pan-cancer |
AAC |
-0.012 |
0.9 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
mRNA |
BRD-K41334119 |
CTRPv2 |
pan-cancer |
AAC |
-0.0067 |
0.9 |
mRNA |
CD-1530 |
CTRPv2 |
pan-cancer |
AAC |
0.0033 |
0.9 |
mRNA |
VAF-347 |
CTRPv2 |
pan-cancer |
AAC |
0.004 |
0.9 |
mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
-0.0026 |
0.9 |
mRNA |
ML006 |
CTRPv2 |
pan-cancer |
AAC |
0.003 |
0.9 |
mRNA |
isoliquiritigenin |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |
mRNA |
RO4929097 |
CTRPv2 |
pan-cancer |
AAC |
-0.0039 |
0.9 |
mRNA |
SNX-2112:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0021 |
0.9 |